Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 5
1971 2
1973 4
1974 3
1975 2
1976 2
1977 3
1978 3
1980 2
1981 3
1982 2
1983 1
1984 1
1986 1
1987 3
1988 1
1989 1
1990 2
1991 3
1992 2
1993 2
1994 5
1995 2
1996 5
1997 8
1998 2
1999 11
2000 5
2001 7
2002 5
2003 5
2004 10
2005 7
2006 11
2007 13
2008 10
2009 11
2010 7
2011 9
2012 11
2013 20
2014 16
2015 26
2016 13
2017 18
2018 14
2019 6
2020 11
2021 9
2022 11
2023 5
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Taylor HS, et al. Among authors: archer df. N Engl J Med. 2017 Jul 6;377(1):28-40. doi: 10.1056/NEJMoa1700089. Epub 2017 May 19. N Engl J Med. 2017. PMID: 28525302 Free article. Clinical Trial.
In reply.
Kaunitz AM, Portman D, Westhoff CL, Archer DF, Mishell DR Jr, Foegh M. Kaunitz AM, et al. Among authors: archer df. Obstet Gynecol. 2014 May;123(5):1107-1108. doi: 10.1097/AOG.0000000000000248. Obstet Gynecol. 2014. PMID: 24785870 No abstract available.
To the Editor.
Archer DF, Pickar JH, Constantine GD, Shadiack AM, Bernick B, Mirkin S. Archer DF, et al. Menopause. 2018 Aug;25(8):952-953. doi: 10.1097/GME.0000000000001146. Menopause. 2018. PMID: 29944639 No abstract available.
Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium.
Lensen S, Paramanandam VS, Gabes M, Kann G, Donhauser T, Waters NF, Li AD, Peate M, Susanto NS, Caughey LE, Rangoonwal F, Liu J, Condron P, Anagnostis P, Archer DF, Avis NE, Bell RJ, Carpenter JS, Chedraui P, Christmas M, Davies M, Hillard T, Hunter MS, Iliodromiti S, Jaff NG, Jaisamrarn U, Joffe H, Khandelwal S, Kiesel L, Maki PM, Mishra GD, Nappi RE, Panay N, Pines A, Roberts H, Rozenberg S, Rueda C, Shifren J, Simon JA, Simpson P, Siregar MFG, Stute P, Garcia JT, Vincent AJ, Wolfman W, Hickey M. Lensen S, et al. Among authors: archer df. Menopause. 2024 Jul 1;31(7):582-590. doi: 10.1097/GME.0000000000002370. Epub 2024 Apr 30. Menopause. 2024. PMID: 38688464
Science of intracrinology in postmenopausal women.
Labrie F, Bélanger A, Pelletier G, Martel C, Archer DF, Utian WH. Labrie F, et al. Among authors: archer df. Menopause. 2017 Jun;24(6):702-712. doi: 10.1097/GME.0000000000000808. Menopause. 2017. PMID: 28098598 Review.
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, Apolikhina I, Bouchard C, Archer DF, Jost M, Foidart JM, Creinin M. Chen MJ, et al. Among authors: archer df. Contraception. 2022 Dec;116:44-50. doi: 10.1016/j.contraception.2022.10.004. Epub 2022 Oct 17. Contraception. 2022. PMID: 36257374 Free article. Clinical Trial.
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.
Hughes SM, Levy CN, Katz R, Lokken EM, Anahtar MN, Hall MB, Bradley F, Castle PE, Cortez V, Doncel GF, Fichorova R, Fidel PL Jr, Fowke KR, Francis SC, Ghosh M, Hwang LY, Jais M, Jespers V, Joag V, Kaul R, Kyongo J, Lahey T, Li H, Makinde J, McKinnon LR, Moscicki AB, Novak RM, Patel MV, Sriprasert I, Thurman AR, Yegorov S, Mugo NR, Roxby AC, Micks E, Hladik F; Consortium for Assessing Immunity Across the Menstrual Cycle. Hughes SM, et al. BMC Med. 2022 Oct 5;20(1):353. doi: 10.1186/s12916-022-02532-9. BMC Med. 2022. PMID: 36195867 Free PMC article.
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy.
Bouchard C, Labrie F, Archer DF, Portman DJ, Koltun W, Elfassi É, Grainger DA, Ayotte N, Cooper TA, Martens M, Waldbaum AS, Labrie C, Côté I, Lavoie L, Martel C, Balser J; VVA Prasterone Group. Bouchard C, et al. Among authors: archer df. Climacteric. 2015;18(4):590-607. doi: 10.3109/13697137.2014.992012. Epub 2015 Mar 3. Climacteric. 2015. PMID: 25511551 Clinical Trial.
323 results